SYN Key Stats
- SYNTHETIC BIOLOGICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Yahoo 03/04 09:16 ET
- Synthetic Biologics' Board of Directors Accepts Resignation of Long-Standing Founder and Board Member noodls 02/26 17:45 ET
- SYNTHETIC BIOLOGICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh Yahoo 02/26 17:14 ET
- Synthetic Biologics Under The Radar With Upcoming Multiple Sclerosis Data Catalyst Yahoo 02/19 07:55 ET
- Synthetic Biologics (SYN) Worth Watching: Stock Soars 19.8% Yahoo 02/14 06:54 ET
- Synthetic Biologics (SYN) Worth Watching: Stock Soars 19.8% - Tale of the Tape Zacks 02/14 03:46 ET
- 3:58 pm Synthetic Biologics states that its policy is not to comment on unusual market activity Yahoo 02/13 17:55 ET
- Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity noodls 02/13 16:35 ET
- Synthetic Biologics (SYN) Won't Commen on Unusual Activity Street Insider 02/13 16:00 ET
- Synthetic Biologics Announces Rhonda Voskuhl, M.D., to Present Trimesta™ Phase II Multiple Sclerosis Clinical Trial Results at the 2014 AAN Annual Meeting noodls 02/10 10:34 ET
SYN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Synthetic Biologics is up 51.96% over the last year vs S&P 500 Total Return up 24.45%, Coronado Biosciences down 68.08%, and Emergent BioSolutions up 82.46%.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for SYN
Pro Strategies Featuring SYN
Did Synthetic Biologics make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: United States
- Headquarters State/Province: Maryland
- Incorporation Country: United States
- Incorporation State/Province: Nevada
Synthetic Biologics Inc. is a biotechnology company engaged in the development of biologics for the prevention and treatment of serious infectious diseases.